VerGo Pharma Research: Your Trusted Partner in Pharma Development

The pharmaceutical industry is rapidly evolving, with increasing demands for innovative drug development, stringent regulatory compliance, and faster time-to-market. To navigate these complexities, pharmaceutical companies require a reliable Contract Development and Manufacturing Organization (CDMO) that offers end-to-end solutions for drug development and manufacturing. At VerGo Pharma Research, we take pride in being a trusted partner […]
What Makes VerGo Pharma Research a Reliable CDMO in Pharma?

In the dynamic landscape of pharmaceutical development, Contract Development and Manufacturing Organizations (CDMOs) play a crucial role in bringing innovative drug formulations to the market. With stringent regulatory requirements and increasing competition, choosing the right CDMO is essential for pharmaceutical companies. VerGo Pharma Research in Goa, India, stands out as a reliable and top CDMO […]
VerGo’s End-to-End Support to Bioequivalence Studies

In the ever-evolving landscape of pharmaceutical development, bioequivalence (BE) studies play a pivotal role in ensuring the safety, efficacy, and regulatory compliance of generic medicines. For pharmaceutical companies aiming to enter global or regional markets, BE studies serve as the cornerstone for regulatory approval of generic drugs. To navigate this complex terrain, many pharmaceutical innovators […]
How VerGo Supports Generic Formulation Development

In the dynamic and ever-evolving world of pharmaceuticals, generic drugs play a pivotal role in making essential medicines accessible and affordable to millions across India and globally. The journey from a patent-expired innovator drug to a robust, bioequivalent generic formulation is intricate, demanding unparalleled scientific expertise, cutting-edge infrastructure, and stringent regulatory adherence. This is where […]
Pharmaceutical Liquid Product Formulation Development for Global Markets

In today’s evolving pharmaceutical landscape, liquid dosage forms play a pivotal role in improving drug delivery, patient compliance, and therapeutic outcomes. As the global demand for patient-friendly and bioavailable medicines increases, the development of pharmaceutical liquid products has become a critical focus area for drug manufacturers and contract development organisations (CDMOs) alike. Based in Goa, […]
Why stability study is important in Pharma?

Introduction In the pharmaceutical industry, quality is non-negotiable. Every medicine that reaches a patient must be safe, effective, and consistent throughout its shelf life. One of the most critical tools to ensure this is the stability study in pharmaceuticals. By conducting structured stability testing, companies can determine how long a drug remains effective, under what […]
Technology Transfer in Pharma: How VerGo Enables Seamless Site Transfers and Scale-Up

Technology transfer is one of the most critical steps in a pharmaceutical product’s lifecycle. It ensures that a formulation developed in the R&D lab can be successfully reproduced at pilot, validation, and commercial manufacturing scales without compromising quality, safety, or regulatory compliance. For pharma companies across India, Europe, and regulated global markets, a smooth tech […]
The CDMO of 2026: From Batch Manufacturing to End-to-End Innovation Partners

The pharmaceutical outsourcing landscape is undergoing a fundamental shift. As we approach 2026, Contract Development and Manufacturing Organizations (CDMOs) are no longer viewed merely as external production units for clinical or commercial batches. Instead, they are increasingly expected to act as end-to-end innovation partners, supporting pharmaceutical companies across the entire product lifecycle—from early development to […]
What Are Clinical Endpoints Studies & How They Impact Drug Approval Success

In the pharmaceutical world, developing a new drug is long, intricate journey that involves numerous stages. One of the most crucial steps in this process is clinical endpoints studies. These studies serve as a fundamental part of clinical trials, guiding regulatory agencies in determining whether a drug should be approved for public use. In this […]